Osmosis.org from Elsevier · 1 month ago
Elsevier Clinical Content Reviewer, Specialty Specific (Part-Time, Fixed Term Contract)
Osmosis is a global leader in information and analytics dedicated to advancing science and improving health outcomes. The Clinical Content Reviewer will work closely with data and content teams to ensure accuracy of clinical content, providing feedback throughout the development cycle.
EducationHealth CareMedical
Responsibilities
Collaborate with our multidisciplinary team to create and curate content focused on emerging medical technologies
Create, rate, and rank queries based on their relevance, safety, and efficacy, helping healthcare professionals make informed decisions
Review and assess the potential impact of various technologies on medical practice, patient care, and clinical outcomes
Stay abreast of the latest advancements in the field of healthcare technology to ensure the content remains current and up-to-date
Provide expert insights and perspectives on the integration of emerging technologies in clinical settings
Qualification
Required
Terminal medical degree (MD or DO), specializing in one of the following: Family Medicine, Radiology, Pathology, Anesthesiology, OB/GYN, and General Surgery
At least 2 years of post-residency clinical experience
Active and unencumbered US-based license
Direct point of care experience within the US
Demonstrated interest and engagement with emerging technologies
Be comfortable working autonomously in a fully remote environment, must have proficiency in Microsoft Office (Outlook, Teams, and Excel)
Benefits
Gain access to Elsevier Health products
Join a community of talented clinicians
Have an impact on the next generation of health solutions
Promote a healthy work/life balance
Numerous wellbeing initiatives
Shared parental leave
Study assistance
Sabbaticals
Working flexible hours
Company
Osmosis.org from Elsevier
Osmosis.org is a leading health education platform with an audience of millions of current and future healthcare professionals and their patients and family members (https://www.osmosis.org/world).
Funding
Current Stage
Growth StageTotal Funding
$6.65MKey Investors
FelicisGregory ColemanTEDCO
2021-11-29Acquired
2020-12-29Series A
2019-06-11Series A· $4M
Recent News
Portfolio Adviser
2025-12-02
Institutional Investor
2025-10-12
Company data provided by crunchbase